

Apollo Utrecht: Which cancers are we treating, and why? by Dr. Thijs Koorman
โMonthly series are back with the November event! ๐
โThis month, we welcome Dr. Thijs Koorman from the Bovenschen group at University Medical Center Utrecht.
โInvasive cancer is largely incurable. There are exceptions, but once cancer has metastasized, treatment focuses mainly on improving quality of life or prolonging survival. Recent advances, especially cell-based immunotherapies, have transformed the treatment of blood cancers, but their effectiveness against solid tumors remains elusive.
โAt the meeting, Thijs will open a discussion about this unmet need. What are we treating, and why? Have survival rates really improved despite billions of dollars and more than 25 years of investment? We will explore these questions using invasive cancer as a scientific model.
โAbout the speaker
โThijs explains this better than us: http://thijskoorman.com/?page_id=15
โWhy join?
โCome along if youโre curious about why cancer is so hard to cure, and whether our treatments are really getting better.
โ๐ Lecture starts at 6 PM
๐ Pizza and good company afterwards